Previous close | 137.94 |
Open | 138.47 |
Bid | 135.68 x 1300 |
Ask | 138.00 x 800 |
Day's range | 136.71 - 140.31 |
52-week range | 71.51 - 145.04 |
Volume | |
Avg. volume | 882,809 |
Market cap | 12.098B |
Beta (5Y monthly) | 1.03 |
PE ratio (TTM) | 15.59 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time.
DaVita, a leading provider of kidney care services, today announced that 54 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of The DAISY Foundation's mission to recognize nurses who provide outstanding, compassionate care in more than 6,500 health care facilities nationwide.
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2024.